Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential

BACKGROUND: The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have published guidelines on the use of cancer treatments in young people of reproductive potential. However, no such guideline is available in Japan. Therefore, this project aimed to gather relevant data and...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Nao, Takai, Yasushi, Yonemura, Masahito, Negoro, Hiromitsu, Motonaga, Shinya, Fujishiro, Noriko, Nakamura, Eishin, Takae, Seido, Yoshida, Saori, Uesugi, Koji, Ohira, Takashi, Katsura, Aiko, Fujiwara, Michio, Horiguchi, Itsuko, Kosaki, Kenjiro, Onodera, Hiroshi, Nishiyama, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023394/
https://www.ncbi.nlm.nih.gov/pubmed/35347493
http://dx.doi.org/10.1007/s10147-022-02149-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023394/
https://www.ncbi.nlm.nih.gov/pubmed/35347493
http://dx.doi.org/10.1007/s10147-022-02149-1

Ejemplares similares